OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Steering New Drug Discovery Campaigns: Permeability, Solubility, and Physicochemical Properties in the bRo5 Chemical Space
Giulia Caron, Jan Kihlberg, Gilles H. Goetz, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 1, pp. 13-23
Open Access | Times Cited: 66

Showing 26-50 of 66 citing articles:

Diversity matters: Widening the chemical space in organic solvent nanofiltration
Gergő Ignácz, Yang Cong, György Székely
Journal of Membrane Science (2021) Vol. 641, pp. 119929-119929
Open Access | Times Cited: 22

Polar/apolar interfaces modulate the conformational behavior of cyclic peptides with impact on their passive membrane permeability
Stephanie M. Linker, Christian Schellhaas, Benjamin Ries, et al.
RSC Advances (2022) Vol. 12, Iss. 10, pp. 5782-5796
Open Access | Times Cited: 14

Refinement of Computational Access to Molecular Physicochemical Properties: From Ro5 to bRo5
Matteo Rossi Sebastiano, Diego García Jiménez, Maura Vallaro, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 18, pp. 12068-12083
Open Access | Times Cited: 14

ent-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic inCasq2−/−Mice
Aaron Gochman, Tri Q., Kyung Soo Kim, et al.
Molecular Pharmacology (2024) Vol. 105, Iss. 3, pp. 194-201
Open Access | Times Cited: 2

The Goldilocks paradigm: comparing classical machine learning, large language models, and few-shot learning for drug discovery applications
Scott Snyder, Patricia A. Vignaux, Mustafa Kemal Ozalp, et al.
Communications Chemistry (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2

Translating PROTAC chemical series optimization into functional outcomes underlying BRD7 and BRD9 protein degradation
Kristin M. Riching, James D. Vasta, Scott J. Hughes, et al.
Current Research in Chemical Biology (2021) Vol. 1, pp. 100009-100009
Open Access | Times Cited: 18

Current screening, design, and delivery approaches to address low permeability of chemically synthesized modalities in drug discovery and early clinical development
Wenzhan Yang, Maya P. Lipert, Rebecca Nofsinger
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103685-103685
Closed Access | Times Cited: 7

In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Moleculeent-Verticilide
Daniel J. Blackwell, Abigail N. Smith, Tri Q., et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 385, Iss. 3, pp. 205-213
Closed Access | Times Cited: 6

Beyond Rule-of-five: Permeability Assessment of Semipeptidic Macrocycles
Marion L'Exact, Christian Comeau, Alix Bourhis, et al.
Biochimica et Biophysica Acta (BBA) - Biomembranes (2023) Vol. 1865, Iss. 7, pp. 184196-184196
Closed Access | Times Cited: 6

To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives
Diana Castagna, Benoit Gourdet, Roland Hjerpe, et al.
Progress in medicinal chemistry (2024), pp. 61-160
Closed Access | Times Cited: 1

Semi-synthesis of a DNA-Tagged Polyketide–Peptide Hybrid Macrocycle Using a Biosynthetically Prepared Fungal Macrolide as a Synthetic Component
Soya Koremura, Akihiro Sugawara, Yohei Morishita, et al.
Organic Letters (2024) Vol. 26, Iss. 42, pp. 9151-9156
Open Access | Times Cited: 1

Data-Driven Parametrization of Molecular Mechanics Force Fields for Expansive Chemical Space Coverage
Tianze Zheng, Ailun Wang, Xu Han, et al.
Chemical Science (2024)
Open Access | Times Cited: 1

Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes
Jiamin Zheng, Dongdong Chen, Jie Xu, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 48, pp. 128229-128229
Closed Access | Times Cited: 12

Passive Membrane Permeability of Sizable Acyclic β-Hairpin Peptides
Jillene Moxam, Sarah Naylon, Alexis D. Richaud, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 3, pp. 278-284
Closed Access | Times Cited: 4

MacroConf – dataset & workflows to assess cyclic peptide solution structures
Daniel Crusius, Jason R. Schnell, Flaviu Cipcigan, et al.
Digital Discovery (2023) Vol. 2, Iss. 4, pp. 1163-1177
Open Access | Times Cited: 4

Design Considerations in Constructing and Screening DNA-Encoded Libraries
Ying Zhang, Raphael M. Franzini
Topics in medicinal chemistry (2022), pp. 123-143
Closed Access | Times Cited: 6

Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined docking and molecular dynamics simulations approach
Afsar Alam, Mohammad S Khan, Yash Mathur, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 11, pp. 5758-5769
Closed Access | Times Cited: 3

Pharmaceutical Development Challenges in a Beyond Rule of Five Prodrug: Case Study of ABBV-167, Phosphate Prodrug of Venetoclax
Richard Hong, Haichen Nie, Rodger F. Henry, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 11, pp. 5811-5826
Closed Access | Times Cited: 3

Addressing Challenges of Macrocyclic Conformational Sampling in Polar and Apolar Solvents: Lessons for Chameleonicity
Xuechen Tang, Janik Kokot, Franz Waibl, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 22, pp. 7107-7123
Open Access | Times Cited: 3

Proline-Hinged α-Helical Peptides Sensitize Gram-Positive Antibiotics, Expanding Their Physicochemical Properties to Be Used as Gram-Negative Antibiotics
Yoonhwa Choi, Hyeong Woon Choe, Minsoo Kook, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 3, pp. 1825-1842
Open Access | Times Cited: 3

Drug discovery: Chaos can be your friend or your enemy
Susan M. Miller, Walter H. Moos, Barbara H. Munk, et al.
Elsevier eBooks (2023), pp. 417-511
Closed Access | Times Cited: 2

Discovering potential inhibitors of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach towards anticancer drug development
Afsha Khan, Mohamed Ahmed Bealy, Bandar Alharbi, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 4, pp. 1846-1857
Closed Access | Times Cited: 2

Adaptation of Empirical Methods to Predict the LogD of Triazine Macrocycles
Casey J. Patterson-Gardner, Gretchen M. Pavelich, April T. Cannon, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 10, pp. 1378-1382
Open Access | Times Cited: 2

Sequence-defined oligophosphoesters for selective inhibition of the KRAS G12D/RAF1 interaction
Bini Claringbold, Steven Vance, Alexandra R. Paul, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Scroll to top